Review Article

Benefits from Treatment and Control of Patients with Resistant Hypertension

Figure 1

Five-year mortality rates (%) in untreated patients with malignant hypertension and Grade III or IV retinopathy compared to similar patients that underwent sympathectomy (modified from Keith et al. [25] and Peet et al. [26]).
318549.fig.001